Edward C. Doo
National Institutes of Health · 80 works · 11,033 citations · h-index 41
Top works
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- Management of hepatitis B
- Long-term therapy of chronic hepatitis B with lamivudine
- Acute liver failure
- Progression of fibrosis in chronic hepatitis C
- Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
- Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease
- Primary sclerosing cholangitis: Summary of a workshop
- Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
- Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis
- Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxycytidine
- Lamivudine for chronic delta hepatitis
- Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
- Antiviral resistance and hepatitis B therapy #
- Hepatitis B Virus X Protein Is both a Substrate and a Potential Inhibitor of the Proteasome Complex
- Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial
- Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis B